Literature DB >> 22239888

Simultaneous right and left heart real-time, free-breathing CMR flow quantification identifies constrictive physiology.

Paaladinesh Thavendiranathan1, David Verhaert, Michael C Walls, Jacob A Bender, Sanjay Rajagopalan, Yiu-Cho Chung, Orlando P Simonetti, Subha V Raman.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate the ability of a novel cardiac magnetic resonance (CMR) real-time phase contrast (RT-PC) flow measurement technique to reveal the discordant respirophasic changes in mitral and tricuspid valve in flow indicative of the abnormal hemodynamics seen in constrictive pericarditis (CP).
BACKGROUND: Definitive diagnosis of CP requires identification of constrictive hemodynamics with or without pericardial thickening. CMR to date has primarily provided morphological assessment of the pericardium.
METHODS: Sixteen patients (age 57 ± 13 years) undergoing CMR to assess known or suspected CP and 10 controls underwent RT-PC that acquired simultaneous mitral valve and tricuspid valve inflow velocities over 10 s of unrestricted breathing. The diagnosis of CP was confirmed via clinical history, diagnostic imaging, cardiac catheterization, intraoperative findings, and histopathology.
RESULTS: Ten patients had CP, all with increased pericardial thickness (6.2 ± 1.0 mm). RT-PC imaging demonstrated discordant respirophasic changes in atrioventricular valve inflow velocities in all CP patients, with mean ± SD mitral valve and tricuspid valve inflow velocity variation of 46 ± 20% and 60 ± 15%, respectively, compared with 16 ± 8% and 24 ± 11% in patients without CP (p < 0.004 vs. patients with CP for both) and 17 ± 5% and 31 ± 13% in controls (p < 0.001 vs. patients with CP for both). There was no difference in atrioventricular valve inflow velocity variation between patients without CP compared with controls (p > 0.3 for both). Respiratory variation exceeding 25% across the mitral valve yielded a sensitivity of 100%, a specificity of 100%, and an area under the receiver-operating characteristic curve of 1.0 to detect CP physiology. Using a cutoff of 45%, variation of transtricuspid valve velocity had a sensitivity of 90%, a specificity of 88%, and an area under the receiver-operating characteristic curve of 0.98.
CONCLUSIONS: Accentuated and discordant respirophasic changes in mitral valve and tricuspid valve inflow velocities characteristic of CP can be identified noninvasively with RT-PC CMR. When incorporated into existing CMR protocols for imaging pericardial morphology, RT-PC CMR provides important hemodynamic evidence with which to make a definite diagnosis of CP.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22239888      PMCID: PMC4560101          DOI: 10.1016/j.jcmg.2011.07.010

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  19 in total

Review 1.  The role of multimodality imaging in the management of pericardial disease.

Authors:  David Verhaert; Ruvin S Gabriel; Douglas Johnston; Bruce W Lytle; Milind Y Desai; Allan L Klein
Journal:  Circ Cardiovasc Imaging       Date:  2010-05       Impact factor: 7.792

2.  Real-time cine MRI of ventricular septal motion: a novel approach to assess ventricular coupling.

Authors:  Marco Francone; Steven Dymarkowski; Maria Kalantzi; Jan Bogaert
Journal:  J Magn Reson Imaging       Date:  2005-03       Impact factor: 4.813

3.  Early and late results of pericardiectomy for constrictive pericarditis.

Authors:  B C McCaughan; H V Schaff; J M Piehler; G K Danielson; T A Orszulak; F J Puga; J R Pluth; D C Connolly; D C McGoon
Journal:  J Thorac Cardiovasc Surg       Date:  1985-03       Impact factor: 5.209

4.  Differentiation of constrictive pericarditis and restrictive cardiomyopathy by Doppler echocardiography.

Authors:  L K Hatle; C P Appleton; R L Popp
Journal:  Circulation       Date:  1989-02       Impact factor: 29.690

Review 5.  Multimodality imaging of pericardial diseases.

Authors:  Kibar Yared; Aaron L Baggish; Michael H Picard; Udo Hoffmann; Judy Hung
Journal:  JACC Cardiovasc Imaging       Date:  2010-06

Review 6.  Constrictive pericarditis in 26 patients with histologically normal pericardial thickness.

Authors:  Deepak R Talreja; William D Edwards; Gordon K Danielson; Hartzell V Schaff; A Jamil Tajik; Henry D Tazelaar; Jerome F Breen; Jae K Oh
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

7.  Constrictive pericarditis in the modern era: novel criteria for diagnosis in the cardiac catheterization laboratory.

Authors:  Deepak R Talreja; Rick A Nishimura; Jae K Oh; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2008-01-22       Impact factor: 24.094

8.  Diagnostic role of Doppler echocardiography in constrictive pericarditis.

Authors:  J K Oh; L K Hatle; J B Seward; G K Danielson; H V Schaff; G S Reeder; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1994-01       Impact factor: 24.094

9.  Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging.

Authors:  T Masui; S Finck; C B Higgins
Journal:  Radiology       Date:  1992-02       Impact factor: 11.105

10.  Clinically suspected constrictive pericarditis: MR imaging assessment of ventricular septal motion and configuration in patients and healthy subjects.

Authors:  Benedetta Giorgi; Nico R A Mollet; Steven Dymarkowski; Frank E Rademakers; Jan Bogaert
Journal:  Radiology       Date:  2003-06-11       Impact factor: 11.105

View more
  23 in total

Review 1.  Constrictive pericarditis: old disease, new approaches.

Authors:  Terrence D Welch; Jae K Oh
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

Review 2.  New Cardiac Imaging Algorithms to Diagnose Constrictive Pericarditis Versus Restrictive Cardiomyopathy.

Authors:  Ahmad Mahmoud; Manish Bansal; Partho P Sengupta
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

3.  Real-time phase contrast magnetic resonance imaging for assessment of haemodynamics: from phantom to patients.

Authors:  Julius Traber; Lennart Wurche; Matthias A Dieringer; Wolfgang Utz; Florian von Knobelsdorff-Brenkenhoff; Andreas Greiser; Ning Jin; Jeanette Schulz-Menger
Journal:  Eur Radiol       Date:  2015-07-19       Impact factor: 5.315

4.  Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis.

Authors:  Giovanni Donato Aquaro; Andrea Barison; Alessandro Cagnolo; Giancarlo Todiere; Massimo Lombardi; Michele Emdin
Journal:  Int J Cardiovasc Imaging       Date:  2015-04-01       Impact factor: 2.357

5.  CArtesian sampling with Variable density and Adjustable temporal resolution (CAVA).

Authors:  Adam Rich; Michael Gregg; Ning Jin; Yingmin Liu; Lee Potter; Orlando Simonetti; Rizwan Ahmad
Journal:  Magn Reson Med       Date:  2019-11-12       Impact factor: 4.668

Review 6.  Multimodality Imaging for the Assessment of Pericardial Diseases.

Authors:  Michael Chetrit; Bo Xu; Beni R Verma; Allan L Klein
Journal:  Curr Cardiol Rep       Date:  2019-04-16       Impact factor: 2.931

7.  Cardiac MR imaging in constrictive pericarditis: multiparametric assessment in patients with surgically proven constriction.

Authors:  Michael A Bolen; Prabhakar Rajiah; Kenya Kusunose; Patrick Collier; Allan Klein; Zoran B Popović; Scott D Flamm
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-12       Impact factor: 2.357

Review 8.  Multimodality imaging of pericardial disease.

Authors:  Paul C Cremer; Deborah H Kwon
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

Review 9.  Advanced flow MRI: emerging techniques and applications.

Authors:  M Markl; S Schnell; C Wu; E Bollache; K Jarvis; A J Barker; J D Robinson; C K Rigsby
Journal:  Clin Radiol       Date:  2016-03-02       Impact factor: 2.350

Review 10.  Multimodality Imaging of Pericardial Diseases.

Authors:  Mouaz H Al-Mallah; Fatimah Almasoudi; Mohamed Ebid; Amjad M Ahmed; Abdelrahman Jamiel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.